Tilray eyes US, European marijuana as it reports Q4 sales rise, wider loss

Canadian cannabis cultivation giant Tilray plans to focus on Europe and the U.S. for its upcoming expansion plans after posting higher-than-expected sales in the fourth quarter.

Marijuana firm Tilray taps ex-Goldman Sachs managing director

Canadian marijuana cultivator Tilray said it is hiring former Goldman Sachs Managing Director Andrew Pucher as chief corporate development officer.

Tilray to accelerate expansion into CBD with Manitoba Harvest acquisition

Cannabis giant Tilray is expanding into the natural foods category with the acquisition of hemp foods company Manitoba Harvest for 419 million Canadian dollars ($319 million) in cash and stock in an effort to capitalize on cannabidiol-infused products in North America.

Cannabis firm Tilray cuts ties with Namaste Technologies following pledge party

A reportedly racy shareholder party hosted by Namaste Technologies has cost the Toronto company its business ties with fast-growing cannabis producer Tilray.

Officials with Tilray confirmed in an email to Marijuana Business Daily that it had “ended its relationship” with Namaste after a highly publicized “pledge party” the firm held for stockholders who promised not to sell company shares for 90 days.

Cannabis stocks: Tilray’s shares jump more than 30% in Nasdaq debut

Canadian medical marijuana producer Tilray stock surged 32% on its first day of trading on the Nasdaq, a signal of a bullish stance towards the cannabis industry.